The 20 Best Acute Monoblastic Leukemia (AmoL) Doctors Near Me in Lake Success, NY

Marina Konopleva, MD, Phd, is Professor, Oncology, Professor, Molecular Pharmacology, Director, Leukemia Program and Co-Director, Blood Cancer Institute, at Montefiore Einstein. Her clinic focus centers on treating patients with hematologic malignancies, with an emphasis on acute myeloid and acute lymphoblastic leukemia. She has additional expertise in treating patients with high-risk myelodysplastic syndrome and chronic myeloid leukemia. Dr. Konopleva is rated as an Elite provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 25 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Leukemia, Myelodysplastic Syndrome (MDS), Bone Marrow Aspiration, and Bone Marrow Transplant.

Ruthee-lu Bayer is a Transplant Surgeon practicing medicine in Lake Success, New York. Dr. Bayer is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 24 other conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Bayer is board certified in American Board Of Internal Medicine.

Craig Devoe, MD, MHCM, is Chief of the Don Monti Division of Medical Oncology and Hematology and Associate Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Board certified in Medical Oncology, Dr. Devoe specializes in gastrointestinal malignancies (colorectal cancer, pancreatic cancer), and cutaneous malignancies (malignant melanoma) at the Monter Cancer Center where he maintains an active practice focused on providing compassionate, personalized, evidence-based multi-disciplinary care. In addition, Dr. Devoe is a research investigator through the Northwell Health Cancer Institute s NCORP (NCI Community Oncology Research Program) grant and industry-sponsored trials. He works closely with the Cancer Institute s clinical trials office in terms of medical oversight of processes and operations, having completed a training program in clinical research design through the Harvard School of Public Health. Dr. Devoe has served as a member of the Alliance Audit Committee performing oversight at other nationally based cancer programs. After earning his medical degree from the State University of New York (SUNY) at Stony Brook School of Medicine, Dr. Devoe trained in internal medicine at NYU Langone Long Island and completed his fellowship in Hematology/Oncology at SUNY Stony Brook. Dr. Devoe furthered his leadership and managerial skills by earning a master s in Health Care Management degree from the Harvard School of Public Health. Dr. Devoe is an active member of the American Medical Association and the American Society of Clinical Oncology. Dr. Devoe is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Pancreatic Cancer, Colorectal Cancer, Familial Colorectal Cancer, Melanoma, and Tissue Biopsy. Dr. Devoe is board certified in American Board Of Internal Medicine/Hematology and American Board Of Internal Medicine/Medical Oncology.

Steven L. Allen, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in benign and malignant hematology, he is the System Head for Benign Hematology for the Northwell Health Cancer Institute. As an attending physician at the Monter Cancer Center, Dr. Allen focuses on providing compassionate, personalized, evidence-based multi-disciplinary care. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Allen has been the principal investigator for numerous drug trials and has collaborated with several basic science labs, resulting in over 150 publications. Among his many professional affiliations, he is most active with the American Society of Hematology, having served in numerous leadership positions and committees. In addition, he is a dedicated member of the American Society of Clinical Oncology, Empire State Hematology and Oncology Society, and the American College of Physicians. Dr. Allen earned his medical degree from the Johns Hopkins School of Medicine. He trained in internal medicine and hematology/oncology at New York Hospital-Weill Cornell Medical Center. Dr. Allen is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 43 other conditions, according to our data. His clinical expertise encompasses Non-Hodgkin Lymphoma, Monoclonal Gammopathy of Undetermined Significance (MGUS), Schnitzler Syndrome, Follicular Lymphoma, and Bone Marrow Aspiration. Dr. Allen is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Erin Jou, MD is an attending physician at the Monter Cancer Center. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Jou is an Assistant Professor at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. Dr. Jou s practice is solely dedicated to the treatment of patients with benign and malignant hematologic disorders where she focusses on providing compassionate, personalized, evidence-based multi-disciplinary care. She is involved in clinical research at Monter Cancer Center and actively enrolls patients in clinical trials. After graduating from the Pennsylvania State University, Dr. Jou earned her medical degree from Jefferson Medical College. She trained in Internal Medical and Hematology/Oncology at Montefiore Medical Center. Dr. Jou is an active member of the American Society of Hematology. Dr. Jou is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 21 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Acute Myeloblastic Leukemia without Maturation, Acute Myeloblastic Leukemia with Maturation, Myelodysplastic Syndrome (MDS), and Bone Marrow Aspiration. Dr. Jou is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Jonathan Kolitz, MD, FACP, is Professor of Medicine at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell. An expert in malignant hematology, he is the System Head for Malignant Hematology for the Northwell Health Cancer Institute where he guides the clinical care and research activities of faculty and fellows. Board certified in Internal Medicine, Hematology and Medical Oncology, Dr. Kolitz has been a member of the Leukemia Core Committee of the CALGB/Alliance since 1993. He has focused on the development, conduct and publication of innovative clinical trials for the treatment of hematologic malignancies, especially acute leukemia. He has been principal investigator for numerous novel drug trials and has been involved in multiple national and international collaborations, leading to over 200 publications. As an attending physician at the Monter Cancer Center, Dr. Kolitz focuses on providing compassionate, personalized, evidence-based care. Dr. Kolitz earned his medical degree from the Yale University School of Medicine. He trained in Internal Medicine at North Shore University Hospital and Hematology and Medical Oncology at Memorial Sloan-Kettering Cancer Center. Dr. Kolitz is an active member of the American Society of Hematology, American Society of Clinical Oncology and the American College of Physicians. Dr. Kolitz is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 46 other conditions, according to our data. His clinical expertise encompasses Leukemia, Chronic B-Cell Leukemia (CBCL), Acute Myeloid Leukemia (AML), Chronic Lymphocytic Leukemia (CLL), and Bone Marrow Aspiration. Dr. Kolitz is board certified in American Board Of Internal Medicine, American Board Of Internal Medicine/Hematology, and American Board Of Internal Medicine/Medical Oncology.

Dr. William Osler famously said, “The good physician treats the disease; the great physician treats the patient who has the disease.” I am a strong believer in individualizing treatment plans unique to each patient based on understanding the patient as a whole and the specifics of their disease. I am committed to each patient’s care and work hard to ensure that every single patient has the most positive clinical outcome. Dr. Goldfinger is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 20 other conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Acute Myeloid Leukemia (AML), Chronic B-Cell Leukemia (CBCL), Bone Marrow Transplant, and Bone Marrow Aspiration.

Susmitha Edappallath is a Hematologist and an Oncologist practicing medicine in Glen Cove, New York. Dr. Edappallath is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). Her clinical expertise encompasses Acute Monoblastic Leukemia (AmoL), Lymphofollicular Hyperplasia, Non-Hodgkin Lymphoma, and Hypereosinophilic Syndrome. Dr. Edappallath is board certified in American Board Of Pathology/Clinical Pathology, American Board Of Pathology/Hematology, and American Board Of Pathology/Blood Banking-Transfusion.

Sandeep Malik is an Internal Medicine provider practicing medicine in Bronx, New York. Dr. Malik is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Malabsorption, Deep Vein Thrombosis, Essential Thrombocythemia, and Intraductal Papilloma.

Esperanza Papadopoulos is a Hematologist and an Oncologist practicing medicine in New York, New York. She has been practicing medicine for over 44 years. Dr. Papadopoulos is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Bone Marrow Transplant, and Colonoscopy. Dr. Papadopoulos is currently accepting new patients.

Ann Jakubowski is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Jakubowski is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 12 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Graft Versus Host Disease (GvHD), Myelodysplastic Syndrome (MDS), Acute Myeloblastic Leukemia without Maturation, and Bone Marrow Transplant. Dr. Jakubowski is currently accepting new patients.

Gail Roboz is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Roboz is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 45 other conditions, according to our data. Her clinical expertise encompasses Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Leukemia, Bone Marrow Aspiration, and Bone Marrow Transplant. Dr. Roboz is currently accepting new patients.

James H. Garvin, MD, PhD, is a board-certified pediatric hematologist-oncologist who specializes in the care of children and adolescents with brain tumors. He is Principal Investigator at CUMC for the Head Start Program of radiation-sparing intensive chemotherapy for infants and young children with brain tumors. He was principal investigator for a Children's Oncolgy Group protocol for childhood ependymoma. He also offers novel therapies for recurrent brain tumors through our program's membership in Developmental Therapeutics Program of the COG. In addition, Dr. Garvin started the pediatric bone marrow transplant program, and continues as a member of the BMT group. He has particular interest in autologous transplant for brain tumors and allogeneic transplant for metabolic disorders and bone marrow failure syndromes, as well as supportive care for BMT patients. Dr. Garvin became interested in pediatric hematology/oncology through research during medical school in the laboratory of a pediatric hematologist. He is a member of numerous professional societies in the field. Dr. Garvin is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). His clinical expertise encompasses Brain Stem Cancer, Medulloblastoma, Glioma, Chronic Graft Versus Host Disease (cGvHD), and Bone Marrow Transplant. Dr. Garvin is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Garvin is currently accepting new patients.

Dr. Justine Kahn is a Pediatric Oncologist and a clinical investigator specializing in survival outcomes, cancer care delivery, and health equity in children and adolescent/young adults (AYA) with Hodgkin lymphoma, non-Hodgkin lymphoma, acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). Dr. Kahn received her MD from the Icahn School of Medicine at Mount Sinai in New York and completed her Pediatric Residency at Mount Sinai Kravis Children’s Hospital in New York. Dr. Kahn completed her Clinical Fellowship in Pediatric Hematology/Oncology at Columbia University Medical Center. While in residency, Dr. Kahn was elected to Alpha Omega Alpha, the national medical honor society which recognizes high educational achievement. During her fellowship, Dr. Kahn served as a Postdoctoral Research Fellow in Cancer-Related Population Sciences supported by the National Cancer Institute for her work in cancer care delivery, health equity, and health outcomes research. Upon graduation from fellowship, Dr. Kahn joined the Pediatric Hematology/Oncology Division at Columbia University Medical Center as an Oncology Instructor and Attending Physician in 2016. She is currently involved in patient care, clinical trials research, and health outcomes research. In June of 2018, Dr. Kahn obtained a Master of Science in Patient Oriented Research at the Columbia Mailman School of Public Health. In July of 2018 she became an Assistant Professor of Pediatrics in the Division of Pediatric Hematology/Oncology/Stem Cell Transplantation.Dr. Kahn is actively conducting research through studies developed in the Dana-Farber Cancer Institute (DFCI) ALL Consortium, the Children's Oncology Group (COG), and at Columbia University. Columbia boasts a strong commitment to health disparities research in one of the most diverse patient populations in the United States. Dr. Kahn has chosen to focus her research efforts on underserved populations because studies suggest that poor access-to-care, low health literacy, and financial stress can all negatively impact survival in children and AYAs with cancer. Dr. Kahn is supported in part by the Lymphoma Research Foundation and recently received an institutional Career Development Award for her ongoing work on survival disparities in children and AYAs with Hodgkin lymphoma. She serves as CUMC site Principal Investigator for the DFCI ALL Consortium. Dr. Kahn is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 11 other conditions, according to our data. Her clinical expertise encompasses Hodgkin Lymphoma, Acute Lymphoblastic Leukemia (ALL), Leukemia, Langerhans Cell Histiocytosis, and Bone Marrow Aspiration. Dr. Kahn is board certified in Pediatrics and Pediatric Hematology-Oncology. Dr. Kahn is currently accepting new patients.

Robert Levy is a Hematologist practicing medicine in Brooklyn, New York. Dr. Levy is rated as an Advanced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 31 other conditions, according to our data. His clinical expertise encompasses Small Lymphocytic Lymphoma (SLL), Upper Tract Urothelial Carcinoma (UTUC), Immune Thrombocytopenic Purpura (ITP), and Adult Immune Thrombocytopenia.

Dmitriy Elkin is a primary care provider, practicing in Internal Medicine in Far Rockaway, New York. Dr. Elkin is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 78 other conditions, according to our data. His clinical expertise encompasses Hypertension, Familial Hypertension, Glucocorticoid-Remediable Aldosteronism, Gastrostomy, and Endoscopy.

Marina Kremyanskaya is an Oncologist practicing medicine in New York, New York. Dr. Kremyanskaya is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 31 other conditions, according to our data. Her clinical expertise encompasses Myelofibrosis, Polycythemia Vera, Essential Thrombocythemia, Bone Marrow Aspiration, and Splenectomy. Dr. Kremyanskaya is currently accepting new patients.

Brian Shaffer is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Shaffer is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Graft Versus Host Disease (GvHD), Acute Myeloid Leukemia (AML), Myelodysplastic Syndrome (MDS), Multiple Myeloma, and Bone Marrow Transplant. Dr. Shaffer is currently accepting new patients.

Carlyn Tan is a Hematologist and an Oncologist practicing medicine in New York, New York. Dr. Tan is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). She is also highly rated in 14 other conditions, according to our data. Her clinical expertise encompasses Multiple Myeloma, Smoldering Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Tan is currently accepting new patients.

Jen Chin is a Hematologist practicing medicine in Long Beach, New York. Dr. Chin is rated as an Experienced provider by MediFind in the treatment of Acute Monoblastic Leukemia (AmoL). He is also highly rated in 11 other conditions, according to our data. His clinical expertise encompasses Polycythemia Vera, Hemochromatosis, Chronic T-Cell Leukemia (CTCL), Anemia, and Bone Marrow Aspiration.